In silico prediction of Ara h 2 T cell epitopes in peanut-allergic children

Clinical and Experimental Allergy

Volumn 43, Issue 1, 2013, Pages 116-127

  Pascal, M ^a,b   Konstantinou, G N ^a,c   Masilamani, M ^a   Lieberman, J ^a   Sampson, H A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c 424 General Army Hospital   (Greece)

Author keywords

Ara h 2; MHC class II; NetMHCII 2.2; NetMHCIIpan 2.0; PBMCs

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE VACCINE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALGORITHM; ALLELE; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; COMPUTER MODEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE LOCUS; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PEANUT ALLERGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY;

2S ALBUMINS, PLANT; ADOLESCENT; ADULT; ALGORITHMS; AMINO ACID SEQUENCE; ANTIGENS, PLANT; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; FEMALE; GLYCOPROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PEANUT HYPERSENSITIVITY; YOUNG ADULT;

EID: 84871687419     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12014     Document Type: Article

References (58)

1. Rudders SA, Banerji A, Vassallo MF, Clark S, Camargo CA Jr. Trends in pediatric emergency department visits for food-induced anaphylaxis. J Allergy Clin Immunol 2010; 126:385-8.
2. Sicherer SH, Sampson HA. Food Allergy. J Allergy Clin Immunol 2010; 125:S116-25.
3. Skolnick HS, Conover-Walker MK, Koerner CB, Sampson HA, Burks W, Wood RA. The natural history of peanut allergy. J Allergy Clin Immunol 2001; 107:367-74.
4. Nicolaou N, Poorafshar M, Murray C et al. Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics. J Allergy Clin Immunol 2010; 125:191-7.
5. Burks W, Sampson HA, Bannon GA. Peanut allergens. Allergy 1998; 53:725-30.
6. Blanc F, Adel-Patient K, Drumare MF, Paty E, Wal JM, Bernard H. Capacity of purified peanut allergens to induce degranulation in a functional in vitro assay: Ara h 2 and Ara h 6 are the most efficient elicitors. Clin Exp Allergy 2009; 39:1277-85.
7. Porterfield HS, Murray KS, Schlichting DG et al. Effector activity of peanut allergens: a critical role for Ara h 2, Ara h 6, and their variants. Clin Exp Allergy 2009; 39:1099-108.
8. Oppenheimer JJ, Nelson HS, Bock SA, Christensen F, Leung DY. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 1992; 90:256-62.
9. Nelson HS, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997; 99:744-51.
10. Moldaver D, Larché M. Immunotherapy with peptides. Allergy 2011; 66:784-91.
11. Casale TB, Stokes JR. Future forms of immunotherapy. J Allergy Clin Immunol 2011; 127:8-15.
12. Grönlund H, Saarne T, Gafvelin G, van Hage M. The major cat allergen, Fel d 1, in diagnosis and therapy. Int Arch Allergy Immunol 2010; 151:265-74.
13. Müller U, Akdis CA, Fricker M et al. Successful immunotherapy with T cell epitope peptides of bee venom phospholipase A2 induces specific T cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998; 101:747-54.
14. Hong SJ, Michael JG, Fehringer A, Leung DY. Pepsin-digested peanut contains T cell epitopes but no IgE epitopes. J Allergy Clin Immunol 1999; 104:473-7.
15. Eiwegger T, Rigby N, Mondoulet L et al. Gastro-duodenal digestion products of the major peanut allergen Ara h 1 retain an allergenic potential. Clin Exp Allergy 2006; 36:1281-8.
16. King N, Helm R, Stanley JS et al. Allergenic characteristics of a modified peanut allergen. Mol Nutr Food Res 2005; 49:963-71.
17. Glaspole IN, de Leon MP, Rolland JM, O'Hehir RE. Characterization of the T cell epitopes of a major peanut allergen, Ara h 2. Allergy 2005; 60:35-40.
18. Prickett SR, Voskamp AL, Dacumos-Hill A, Symons K, Rolland JM, O'Hehir RE. Ara h 2 peptides containing dominant CD41 T cell epitopes: candidates for a peanut allergy therapeutic. J Allergy Clin Immunol 2010; 127:608-15.
19. Nielsen M, Lund O, Buus S, Lundegaard C. MHC class II epitope predictive algorithms. Immunology 2010; 130:319-28.
20. Pizza M, Scarlato V, Masignani V et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000; 287:1816-20.
21. Sampson HA. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 2001; 107:891-6.
22. Beyer K, Morrow E, Li XM et al. Effects of cooking methods on peanut allergenicity. J Allergy Clin Immunol 2001; 107:1077-81.
23. Rammensee HG, Friede T, Stevanoviic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995; 41:178-228.
24. Nielsen M, Lundegaard C, Blicher T et al. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan. PLoS Comput Biol 2008; 4:e1000107.
25. Nielsen M, Lund O. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics 2009; 10:296.
26. Sturniolo T, Bono E, Ding J et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol 1999; 17:555-61.
27. Nielsen M, Justesen S, Lund O, Lundegaard C, Buus S. NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Res 2010; 6:9.
28. Wang P, Sidney J, Kim Y et al. Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics 2010; 11:568.
29. Bui HH, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A. Predicting population coverage of T cell epitope-based diagnostics and vaccines. BMC Bioinformatics 2006; 7:153.
30. Dupont C, Kalach N, Soulaines P, Legoué-Morillon S, Piloquet H, Benhamou PH. Cow's milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity. J Allergy Clin Immunol 2010; 125:1165-7.
31. Clark AT, Islam S, King Y, Deighton J, Anagnostou K, Ewan PW. Successful oral tolerance induction in severe peanut allergy. Allergy 2009; 64:1218-20.
32. Jones SM, Pons L, Roberts JL et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009; 124:292-300.
33. Hofmann AM, Scurlock AM, Jones SM et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 2009; 124:286-91.
34. Blumchen K, Ulbricht H, Staden U et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2010; 126:83-91.
35. Skripak JM, Nash SD, Rowley H et al. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol 2008; 122:1154-60.
36. Buchanan AD, Green TD, Jones SM et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol 2007; 119:199-205.
37. Thyagarajan A, Varshney P, Jones SM et al. Peanut oral immunotherapy is not ready for clinical use. J Allergy Clin Immunol 2010; 126:31-2.
38. NIAID-Sponsored Expert Panel, Boyce JA, Assa'ad A et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010; 126:S1-58.
39. Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2011; 127:18-27.
40. Focke M, Swoboda I, Marth K, Valenta R. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity. Clin Exp Allergy 2010; 40:385-97.
41. Rolland JM, Gardner LM, O'Hehir RE. Allergen-related approaches to immunotherapy. Pharmacol Ther 2009; 121:273-84.
42. Li XM, Srivastava K, Huleatt JW, Bottomly K, Burks AW, Sampson HA. Engineered recombinant peanut protein and heat-killed listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model. J Immunol 2003; 170:3289-95.
43. Li XM, Srivastava K, Grishin A et al. Persistent protective effect of heat-killed Escherichia coli producing 'engineered', recombinant peanut proteins in a murine model of peanut allergy. J Allergy Clin Immunol 2003; 112:159-67.
44. Von Heijne G. The signal peptide. J Membr Biol 1990; 115:195-201.
45. Malherbe L. T cell epitope mapping. Ann Allergy Asthma Immunol 2009; 103:76-9.
46. Zeiler T, Virtanen T. Mapping of human T cell epitopes of allergens. Methods Mol Med 2008; 138:51-6.
47. Kwok WW, Roti M, DeLong JH et al. Direct ex vivo analysis of allergen-specific CD4+ T cells. J Allergy Clin Immunol 2010; 125:1407-9.
48. Bateman EA, Ardern-Jones MR, Ogg GS. Persistent central memory phenotype of circulating Fel d 1 peptide/DRB1*0101 tetramer-binding CD41 T cells. J Allergy Clin Immunol 2006; 118:1350-6.
49. Novak EJ, Liu AW, Gebe JA et al. Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens. J Immunol 2001; 166:6665-70.
50. Day CL, Seth NP, Lucas M et al. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Invest 2003; 112:831-42.
51. Gammon G, Klotz J, Ando D, Sercarz EE. cell repertoire to a multideterminant antigen. Clonal heterogeneity of the T cell response, variation between syngeneic individuals, and in vitro selection of T cell specificities. J Immunol 1990; 144:1571-7.
52. Reece JC, McGregor DL, Geysen HM, Rodda SJ. Scanning for T helper epitopes with human PBMC using pools of short synthetic peptides. J Immunol Methods 1994; 172:241-54.
53. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acid Res 2011; 39:D913-9.
54. Worm M, Lee HH, Kleine-Tebbe J et al. Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy. J Allergy Clin Immunol 2011; 127:89-97.
55. Stanley JS, King N, Burks AW et al. Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2. Arch Biochem Biophys 1997; 342:244-53.
56. Gruber P, Suhr M, Frey A, Becker WM, Hofmann T. Development of an epitope-specific analytical tool for the major peanut allergen Ara h 2 using a high-density multiple-antigenic peptide strategy. Mol Nutr Food Res 2004; 48:449-58.
57. Shreffler WG, Lencer DA, Bardina L, Sampson HA. IgE and IgG4 epitope mapping by microarray immunoassay reveals the diversity of immune response to the peanut allergen, Ara h 2. J Allergy Clin Immunol 2005; 116:893-9.
58. Flinterman AE, Knol EF, Lencer DA, Bardina L, den Hartog Jager CF, Lin J et al. Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy. J Allergy Clin Immunol 2008; 121:737-43.